| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76709-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-66632-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65018-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76642SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65411-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41192-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43332-25ug | |||
![Western Blot: MD-1/LY86 Antibody [NBP1-76709] - Daudi cell lysate with LY86 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/MD-1-LY86-Antibody-Western-Blot-NBP1-76709-img0001.jpg "Western Blot: MD-1/LY86 Antibody [NBP1-76709] - Daudi cell lysate with LY86 antibody at (A) 1 and (B) 2 ug/mL.")
![Immunohistochemistry: MD-1/LY86 Antibody - BSA Free [NBP1-76709] - Immunohistochemistry of MD-1/LY86 in human spleen tissue with MD-1/LY86 antibody at 2.5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76709_rabbit-polyclonal-md-1-ly86-antibody-2711202420212378.jpg)
![Flow Cytometry: CD47 Antibody (OX-101) [NB100-66632] - Staining of Rat Spleen cells with Mouse anti Rat CD47:FITC](http://images.novusbio.com/fullsize/CD47-Antibody-OX-101-Flow-Cytometry-NB100-66632-img0003.jpg "Flow Cytometry: CD47 Antibody (OX-101) [NB100-66632] - Staining of Rat Spleen cells with Mouse anti Rat CD47:FITC")
![Flow Cytometry: CD47 Antibody (OX-101) [NB100-66632] - Staining of Rat Spleen cells with Mouse anti Rat CD47:RPE](http://images.novusbio.com/fullsize/CD47-Antibody-OX-101-Flow-Cytometry-NB100-66632-img0001.jpg)
![Flow Cytometry: CD47 Antibody (OX-101) [NB100-66632] - Staining of Rat Spleen cells with Mouse anti Rat CD47:Alexa Fluor® 647](http://images.novusbio.com/fullsize/CD47-Antibody-OX-101-Flow-Cytometry-NB100-66632-img0002.jpg)
![Flow Cytometry: B220/CD45R Antibody (YKIX753.22.2) [NB100-65018] - Figure A. RPE conjugated Rat anti Canine CD45R and Alexa Fluor 488 conjugated Rat IgG1 isotype control. Figure B. RPE conjugated Mouse anti Canine CD45R and Alexa Fluor 488 conjugated Rat anti Canine CD44.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-YKIX753-22-2-Flow-Cytometry-NB100-65018-img0003.jpg "Flow Cytometry: B220/CD45R Antibody (YKIX753.22.2) [NB100-65018] - Figure A. RPE conjugated Rat anti Canine CD45R and Alexa Fluor 488 conjugated Rat IgG1 isotype control. Figure B. RPE conjugated Mouse anti Canine CD45R and Alexa Fluor 488 conjugated Rat anti Canine CD44.")
![Flow Cytometry: B220/CD45R Antibody (YKIX753.22.2) [NB100-65018] - Figure A. Alexa Fluor 488 conjugated Rat anti Dog CD44 and Alexa Fluor 647 conjugated Rat IgG2b isotype control. Figure B. Alexa Fluor 488 conjugated Rat anti Dog CD44 and Alexa Fluor 647 conjugated Rat anti Dog CD45R.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-YKIX753-22-2-Flow-Cytometry-NB100-65018-img0001.jpg)
![Flow Cytometry: B220/CD45R Antibody (YKIX753.22.2) [NB100-65018] - Figure A. Alexa Fluor 488 conjugated Rat anti Canine CD44 and RPE conjugated Rat IgG2a isotype control. Figure B. Alexa Fluor 488 conjugated Rat anti Canine CD44 and RPE conjugated Rat anti Canine CD45R.](http://images.novusbio.com/fullsize/B220-CD45R-Antibody-YKIX753-22-2-Flow-Cytometry-NB100-65018-img0002.jpg)
![Western Blot: TRAF-3 Antibody [NBP1-76642] - HeLa cell lysate with TRAF3 antibody at (A) 2 and (B) 4 ug/ml.](http://images.novusbio.com/fullsize/TRAF-3-Antibody-Western-Blot-NBP1-76642-img0001.jpg "Western Blot: TRAF-3 Antibody [NBP1-76642] - HeLa cell lysate with TRAF3 antibody at (A) 2 and (B) 4 ug/ml.")
![Immunocytochemistry/ Immunofluorescence: TRAF-3 Antibody - BSA Free [NBP1-76642] - Immunocytochemistry of TRAF-3 in HeLa cells with TRAF-3 antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76642_rabbit-polyclonal-traf-3-antibody-271120242016971.jpg)
![Flow Cytometry: HLA ABC Antibody (YTH862.2) [NB100-65411] - Staining of human peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/HLA-ABC-Antibody-YTH862-2-Flow-Cytometry-NB100-65411-img0001.jpg "Flow Cytometry: HLA ABC Antibody (YTH862.2) [NB100-65411] - Staining of human peripheral blood lymphocytes.")
![Western Blot: CEBP Delta Antibody [NBP2-41192] - Western blot analysis of CEBPD in rat spleen tissue lysate with CEBPD antibody at 0.5 ug/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/CEBP-Delta-Antibody-Western-Blot-NBP2-41192-img0001.jpg "Western Blot: CEBP Delta Antibody [NBP2-41192] - Western blot analysis of CEBPD in rat spleen tissue lysate with CEBPD antibody at 0.5 ug/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: CEBP Delta Antibody - BSA Free [NBP2-41192] - Immunofluorescence of CEBP Delta in human spleen tissue with CEBP Delta antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp2-41192_rabbit-polyclonal-cebp-delta-antibody-2711202419293847.jpg)
![Flow Cytometry: CCR7 Antibody (3D12) [NBP1-43332] - Analysis using the PE conjugate of NBP1-43332. Analysis of human peripheral blood cells using CCR7 PE conjugate. This can be used at less than or equal to 0.5 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.](http://images.novusbio.com/fullsize/CCR7-Antibody-3D12-Flow-Cytometry-NBP1-43332-img0006.jpg "Flow Cytometry: CCR7 Antibody (3D12) [NBP1-43332] - Analysis using the PE conjugate of NBP1-43332. Analysis of human peripheral blood cells using CCR7 PE conjugate. This can be used at less than or equal to 0.5 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.")
![Flow Cytometry: CCR7 Antibody (3D12) [NBP1-43332] - Analysis using the Allophycocyanin conjugate of NBP1-43332. Staining of normal human peripheral blood cells with Anti-Human CD45RA FITC and Rat IgG2a ? Isotype Control APC (left) or Anti-Human CD197 (CCR7) APC (right).](http://images.novusbio.com/fullsize/CCR7-Antibody-3D12-Flow-Cytometry-NBP1-43332-img0004.jpg)
![Flow Cytometry: CCR7 Antibody (3D12) [NBP1-43332] - Analysis using the Biotin conjugate of NBP1-43332. Staining of normal human peripheral blood cells with Anti-Human CD45RA FITC and 1.0 micrograms of Rat IgG2a k Isotype Control Biotin (left) or 1.0 micrograms of Anti-Human CD197 (CCR7) Biotin (right) followed by Streptavidin PE. Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CCR7-Antibody-3D12-Flow-Cytometry-NBP1-43332-img0005.jpg)
![Western Blot: CES1 Antibody [NBP1-00167] - Analysis of CES1 in Human Liver lysate (35ug protein in RIPA buffer) using NBP1-00167 at 0.3ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/CES1-Antibody-Western-Blot-NBP1-00167-img0005.jpg "Western Blot: CES1 Antibody [NBP1-00167] - Analysis of CES1 in Human Liver lysate (35ug protein in RIPA buffer) using NBP1-00167 at 0.3ug/ml. Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunohistochemistry-Paraffin: CES1 Antibody [NBP1-00167] - (2.5ug/ml) staining of paraffin embedded Human Lung. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/CES1-Antibody-Immunohistochemistry-Paraffin-NBP1-00167-img0004.jpg)
![Western Blot: BOB1 Antibody [NB100-1122] - Analysis of BOB1 in Mouse Spleen lysate at 2 ug/ ml.](http://images.novusbio.com/fullsize/BOB1-Antibody-Western-Blot-NB100-1122-img0006.jpg "Western Blot: BOB1 Antibody [NB100-1122] - Analysis of BOB1 in Mouse Spleen lysate at 2 ug/ ml.")
![Western Blot: BOB1 Antibody [NB100-1122] - Staining (2ug/ml) of Mouse Spleen lysate (RIPA buffer, 30ug total protein per lane). Primary incubated for 1 hour. Detected by western blot using chemiluminescence.](http://images.novusbio.com/fullsize/BOB1-Antibody-Western-Blot-NB100-1122-img0004.jpg)
![Western Blot: proBNP Antibody (50E1) [NB200-440] - Analysis using the Biotin conjugate of NB200-440. Detection of synthetic huBNP in WB after Tricine-SDS-PAGE in reducing conditions.](http://images.novusbio.com/fullsize/proBNP-Antibody-50E1-Western-Blot-NB200-440-img0006.jpg "Western Blot: proBNP Antibody (50E1) [NB200-440] - Analysis using the Biotin conjugate of NB200-440. Detection of synthetic huBNP in WB after Tricine-SDS-PAGE in reducing conditions.")
![Western Blot: proBNP Antibody (50E1) [NB200-440] - Immunodetection of human synthetic BNP (A), recombinant proBNP (E. coli) (B) and recombinant proBNP (mammalian cell line) (C) in Western blotting by different monoclonal antibodies after Tricine- SDS-PAGE under reducing conditions. A, B. Lanes: 1- MAb 24C511-17, 2- MAb 26E211-22, 3- MAb 2G9, 4- MAb 43B1226-32, 5- MAb 50B726-32, 6- MAb 50E126-32, 7- MAb 57H326-32.](http://images.novusbio.com/fullsize/proBNP-Antibody-50E1-Western-Blot-NB200-440-img0004.jpg)
![Immunoassay: proBNP Antibody (50E1) [NB200-440] - Gel-filtration studies of endogenous proBNP and BNP. BNP immunoreactivity measurements in fractions after proteins from plasma of HF patients were separated by gel-filtration on Superdex Peptide column (GEHealthcare). One representative plasma sample. BNP immunoreactivity was measured by 50E126-32-24C511-17 assay (- -). The first peak corresponds to proBNP, the second corresponds to BNP form.](http://images.novusbio.com/fullsize/proBNP-Antibody-50E1-Immunoassay-NB200-440-img0003.jpg)
![Western Blot: CD40 Ligand/TNFSF5 Antibody [NBP1-59186] - Sample Type: Human Fetal Muscle Lane A: Primary Antibody Lane B: Primary Antibody + Blocking Peptide Primary Antibody Concentration: 1 ug/ml Peptide Concentration: 5 ug/ml Lysate Quantity: 25 ug/lane/lane Gel Concentration: 0.12](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Western-Blot-NBP1-59186-img0006.jpg "Western Blot: CD40 Ligand/TNFSF5 Antibody [NBP1-59186] - Sample Type: Human Fetal Muscle Lane A: Primary Antibody Lane B: Primary Antibody + Blocking Peptide Primary Antibody Concentration: 1 ug/ml Peptide Concentration: 5 ug/ml Lysate Quantity: 25 ug/lane/lane Gel Concentration: 0.12")
![Immunohistochemistry-Paraffin: CD40 Ligand/TNFSF5 Antibody [NBP1-59186] - Human thymus tissue at an antibody concentration of 5ug/ml.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Immunohistochemistry-Paraffin-NBP1-59186-img0005.jpg)
![Western Blot: CD40 Ligand/TNFSF5 Antibody [NBP1-59186] - Titration: 0.2-1 ug/ml, Positive Control: Human Muscle.](http://images.novusbio.com/fullsize/CD40-Ligand-TNFSF5-Antibody-Western-Blot-NBP1-59186-img0004.jpg)
![Flow Cytometry: CD200/OX2 Antibody (OX-104) [NB100-64860] - Surface staining of CD200 in human peripheral blood with CD200/OX2 antibody (conjugated to FITC).](http://images.novusbio.com/fullsize/CD200-OX2-Antibody-OX-104-Flow-Cytometry-NB100-64860-img0003.jpg "Flow Cytometry: CD200/OX2 Antibody (OX-104) [NB100-64860] - Surface staining of CD200 in human peripheral blood with CD200/OX2 antibody (conjugated to FITC).")
![Flow Cytometry: CD200/OX2 Antibody (OX-104) [NB100-64860] - Surface staining of CD200 in human peripheral blood with CD200/OX2 antibody (conjugated to PE).](http://images.novusbio.com/fullsize/CD200-OX2-Antibody-OX-104-Flow-Cytometry-NB100-64860-img0001.jpg)
![Flow Cytometry: CD200/OX2 Antibody (OX-104) [NB100-64860] - Surface staining of CD200 in human peripheral blood with CD200/OX2 antibody (conjugated to APC).](http://images.novusbio.com/fullsize/CD200-OX2-Antibody-OX-104-Flow-Cytometry-NB100-64860-img0002.jpg)